Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Redner

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|October 29, 2009
Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicinWassim McHayleh, Rajesh Sehgal, Robert L Redner, et al.
British Journal of Haematology|November 20, 2008
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trialsJames N George, Susan D Mathias, Ronald S Go, et al.
Leukemia Research|February 15, 2011
Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapyDhaval R Mehta, Kenneth A Foon, Robert L Redner, et al.
British Journal of Clinical Pharmacology|September 11, 2009
Effect of a proton pump inhibitor on the pharmacokinetics of imatinibMerrill J Egorin, Dhvani D Shah, Susan M Christner, et al.
Oncology Research|February 24, 2015
Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemiaKelly Ross, Amanda L Gillespie-Twardy, Mounzer Agha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemiaSteven D Gore, Ivana Gojo, Mikkael A Sekeres, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 30, 2016
Leukapheresis in patients newly diagnosed with acute myeloid leukemiaVipin Villgran, Mounzer Agha, Anastasios Raptis, et al.
Oncology Research|June 15, 2016
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First RelapseAnnie Im, Ali Amjad, Mounzer Agha, et al.
Hematological Oncology|July 1, 2017
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemiaMatthew J Lim, Aya Agha, Annie Im, et al.
Oncology Research|August 6, 2020
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete RemissionArisha Patel, Mounzer Agha, Anastasios Raptis, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|October 29, 2009
Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicinWassim McHayleh, Rajesh Sehgal, Robert L Redner, et al.
British Journal of Haematology|November 20, 2008
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trialsJames N George, Susan D Mathias, Ronald S Go, et al.
Leukemia Research|February 15, 2011
Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapyDhaval R Mehta, Kenneth A Foon, Robert L Redner, et al.
British Journal of Clinical Pharmacology|September 11, 2009
Effect of a proton pump inhibitor on the pharmacokinetics of imatinibMerrill J Egorin, Dhvani D Shah, Susan M Christner, et al.
Oncology Research|February 24, 2015
Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemiaKelly Ross, Amanda L Gillespie-Twardy, Mounzer Agha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemiaSteven D Gore, Ivana Gojo, Mikkael A Sekeres, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 30, 2016
Leukapheresis in patients newly diagnosed with acute myeloid leukemiaVipin Villgran, Mounzer Agha, Anastasios Raptis, et al.
Oncology Research|June 15, 2016
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First RelapseAnnie Im, Ali Amjad, Mounzer Agha, et al.
Hematological Oncology|July 1, 2017
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemiaMatthew J Lim, Aya Agha, Annie Im, et al.
Oncology Research|August 6, 2020
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete RemissionArisha Patel, Mounzer Agha, Anastasios Raptis, et al.
Pageof 5